全文获取类型
收费全文 | 31652篇 |
免费 | 1837篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 448篇 |
儿科学 | 1278篇 |
妇产科学 | 925篇 |
基础医学 | 5133篇 |
口腔科学 | 725篇 |
临床医学 | 2585篇 |
内科学 | 6217篇 |
皮肤病学 | 782篇 |
神经病学 | 3359篇 |
特种医学 | 1359篇 |
外国民族医学 | 14篇 |
外科学 | 4160篇 |
综合类 | 144篇 |
一般理论 | 4篇 |
预防医学 | 1771篇 |
眼科学 | 629篇 |
药学 | 1776篇 |
中国医学 | 32篇 |
肿瘤学 | 2225篇 |
出版年
2023年 | 152篇 |
2022年 | 241篇 |
2021年 | 481篇 |
2020年 | 340篇 |
2019年 | 450篇 |
2018年 | 556篇 |
2017年 | 462篇 |
2016年 | 623篇 |
2015年 | 665篇 |
2014年 | 853篇 |
2013年 | 1092篇 |
2012年 | 1647篇 |
2011年 | 1706篇 |
2010年 | 893篇 |
2009年 | 939篇 |
2008年 | 1542篇 |
2007年 | 1602篇 |
2006年 | 1517篇 |
2005年 | 1548篇 |
2004年 | 1304篇 |
2003年 | 1292篇 |
2002年 | 1210篇 |
2001年 | 950篇 |
2000年 | 972篇 |
1999年 | 852篇 |
1998年 | 426篇 |
1997年 | 328篇 |
1996年 | 268篇 |
1995年 | 243篇 |
1994年 | 209篇 |
1993年 | 214篇 |
1992年 | 487篇 |
1991年 | 513篇 |
1990年 | 501篇 |
1989年 | 418篇 |
1988年 | 398篇 |
1987年 | 412篇 |
1986年 | 402篇 |
1985年 | 395篇 |
1984年 | 276篇 |
1983年 | 215篇 |
1981年 | 148篇 |
1979年 | 262篇 |
1978年 | 184篇 |
1977年 | 156篇 |
1976年 | 152篇 |
1975年 | 166篇 |
1974年 | 195篇 |
1973年 | 168篇 |
1972年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
2.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
3.
4.
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
5.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
6.
Die Unfallchirurgie - Zur Diagnostik von Schultergelenkerkrankungen wird routinemäßig die Magnetresonanztomographie (MRT) durchgeführt. Diese kann entsprechend der klinischen... 相似文献
7.
8.
9.
10.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3